Cargando…
T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621540/ http://dx.doi.org/10.1097/01.HS9.0000890796.34979.cc |
| _version_ | 1784821580752224256 |
|---|---|
| author | Lynch, Ryan C. Alig, Stefan Ujjani, Chaitra S. Poh, Christina Warren, Edus H. Smith, Stephen D. Shadman, Mazyar Shustov, Andrei Till, Brian Raghunathan, Vikram M. Tseng, Yolanda Coye, Hilary Shelby, Megan Ottemiller, Susan Keo, Sarith Verni, Kaitlin Du, Hongyan Vandermeer, Jackie Gaston, Ashley Rasmussen, Heather Gulhane, Avanti Chen, Delphine L. Martin, Paul Marzbani, Edmond Voutsinas, Jenna Alizadeh, Ash A. Gopal, Ajay K. |
| author_facet | Lynch, Ryan C. Alig, Stefan Ujjani, Chaitra S. Poh, Christina Warren, Edus H. Smith, Stephen D. Shadman, Mazyar Shustov, Andrei Till, Brian Raghunathan, Vikram M. Tseng, Yolanda Coye, Hilary Shelby, Megan Ottemiller, Susan Keo, Sarith Verni, Kaitlin Du, Hongyan Vandermeer, Jackie Gaston, Ashley Rasmussen, Heather Gulhane, Avanti Chen, Delphine L. Martin, Paul Marzbani, Edmond Voutsinas, Jenna Alizadeh, Ash A. Gopal, Ajay K. |
| author_sort | Lynch, Ryan C. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9621540 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-96215402022-11-01 T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume Lynch, Ryan C. Alig, Stefan Ujjani, Chaitra S. Poh, Christina Warren, Edus H. Smith, Stephen D. Shadman, Mazyar Shustov, Andrei Till, Brian Raghunathan, Vikram M. Tseng, Yolanda Coye, Hilary Shelby, Megan Ottemiller, Susan Keo, Sarith Verni, Kaitlin Du, Hongyan Vandermeer, Jackie Gaston, Ashley Rasmussen, Heather Gulhane, Avanti Chen, Delphine L. Martin, Paul Marzbani, Edmond Voutsinas, Jenna Alizadeh, Ash A. Gopal, Ajay K. Hemasphere Immunotherapy Lippincott Williams & Wilkins 2022-10-03 /pmc/articles/PMC9621540/ http://dx.doi.org/10.1097/01.HS9.0000890796.34979.cc Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Immunotherapy Lynch, Ryan C. Alig, Stefan Ujjani, Chaitra S. Poh, Christina Warren, Edus H. Smith, Stephen D. Shadman, Mazyar Shustov, Andrei Till, Brian Raghunathan, Vikram M. Tseng, Yolanda Coye, Hilary Shelby, Megan Ottemiller, Susan Keo, Sarith Verni, Kaitlin Du, Hongyan Vandermeer, Jackie Gaston, Ashley Rasmussen, Heather Gulhane, Avanti Chen, Delphine L. Martin, Paul Marzbani, Edmond Voutsinas, Jenna Alizadeh, Ash A. Gopal, Ajay K. T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title | T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title_full | T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title_fullStr | T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title_full_unstemmed | T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title_short | T057: Circulating tumor DNA in classical Hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| title_sort | t057: circulating tumor dna in classical hodgkin lymphoma patients treated with pembrolizumab and chemotherapy: dynamic response assessment and correlation with baseline total metabolic tumor volume |
| topic | Immunotherapy |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9621540/ http://dx.doi.org/10.1097/01.HS9.0000890796.34979.cc |
| work_keys_str_mv | AT lynchryanc t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT aligstefan t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT ujjanichaitras t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT pohchristina t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT warrenedush t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT smithstephend t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT shadmanmazyar t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT shustovandrei t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT tillbrian t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT raghunathanvikramm t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT tsengyolanda t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT coyehilary t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT shelbymegan t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT ottemillersusan t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT keosarith t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT vernikaitlin t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT duhongyan t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT vandermeerjackie t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT gastonashley t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT rasmussenheather t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT gulhaneavanti t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT chendelphinel t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT martinpaul t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT marzbaniedmond t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT voutsinasjenna t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT alizadehasha t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume AT gopalajayk t057circulatingtumordnainclassicalhodgkinlymphomapatientstreatedwithpembrolizumabandchemotherapydynamicresponseassessmentandcorrelationwithbaselinetotalmetabolictumorvolume |